COMPANY RESEARCH PROFILE · UPDATED 2026-09-29

Daiichi Sankyo

Global pharmaceutical company with a major oncology franchise led by antibody-drug conjugates, including HER2-directed Enhertu and TROP2-directed Datroway.

TICKER4568.T

HEADQUARTERSTokyo, Japan

STAGEApproved

ACTIVE TRIALS69

Therapeutic areas

OncologyCardiovascular

Selected products and programs

EnhertuDatroway

Linked curated drug profiles

datopotamab deruxtecan

TROP2-directed antibody-drug conjugate

trastuzumab deruxtecan

HER2-directed antibody-drug conjugate

Selected active clinical trials

A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)

Phase 3 · Recruiting · Advanced Cancer

Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer

Phase 3 · Recruiting · Breast Cancer

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Phase 3 · Recruiting · Small Cell Lung Cancer

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

Phase 3 · Recruiting · Esophageal Squamous Cell Carcinoma

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

Phase 3 · Recruiting · Gastric Cancer

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

Phase 3 · Recruiting · Ovarian Cancer

Selected patent records

No linked FDA Orange Book patent record was found for the selected products.

Primary and company sources

Company and pipeline information can change. Verify material decisions against the linked primary sources.

Evidence & limits

Source: Open the source record

Record identifier: /companies/daiichi-sankyo/
Event / action date: Not separately retained
Source update date: Not separately retained
Platform retrieval / processing date: Not separately retained

What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.

Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.

Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.

What this record means · Report an issue with this record